AVADEL PHARMACEUTICALS PLC Annual Costs and Expenses in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
  • Avadel Pharmaceuticals Plc Costs and Expenses for the quarter ending September 30, 2023 was $42M, a 148% increase year-over-year.
  • Avadel Pharmaceuticals Plc Costs and Expenses for the twelve months ending September 30, 2023 was $144M, a 46.3% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2022 was $98.6M, a 15.2% increase from 2021.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2021 was $85.5M, a 418% increase from 2020.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2020 was $16.5M, a 80.2% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $98.6M +$13M +15.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-29
2021 $85.5M +$69M +418% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $16.5M -$66.8M -80.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $83.3M -$125M -60% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 $208M +$124M +149% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $83.7M -$71.5M -46% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $155M +$53M +51.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $102M -$6.38M -5.87% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $109M +$50.8M +87.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
2013 $57.9M +$40.4M +232% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $17.4M -$24.7M -58.6% Jan 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
2011 $42.2M -$4.75M -10.1% Jan 1, 2011 Dec 31, 2011 20-F/A 2014-04-30
2010 $46.9M Jan 1, 2010 Dec 31, 2010 20-F 2013-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.